Maternal Serum Screen 2 Advanced Reflex to Maternal Blood for Fetal DNA MBFD Chromosome 21 Test
Introduction
The Maternal Serum Screen 2 Advanced Reflex to Maternal Blood for Fetal DNA MBFD Chromosome 21 Test is a vital prenatal screening tool designed to assess the risk of chromosomal abnormalities in the developing fetus, particularly Down syndrome. This test is especially important for expectant mothers who may have increased risk factors for genetic disorders.
What the Test Measures
This test evaluates several key biomarkers in the maternal serum, including:
- PAPP-A (Pregnancy-Associated Plasma Protein A)
- Free Beta HCG (Human Chorionic Gonadotropin)
- Risk Evaluation
- MBFD-21 (Maternal Blood for Fetal DNA)
These components help in calculating the risk of chromosomal abnormalities.
Who Should Consider This Test?
Expectant mothers who should consider this test include those with:
- Advanced maternal age (over 35 years)
- A family history of genetic disorders
- Previous pregnancies with chromosomal abnormalities
- Other risk factors such as diabetes, IVF, or smoking
Benefits of Taking the Test
- Early detection of potential chromosomal abnormalities
- Informed decision-making regarding pregnancy management
- Peace of mind for expectant parents
- Accurate results using advanced testing methods
Understanding Your Results
Results from the Maternal Serum Screen will provide a risk assessment for chromosomal abnormalities. A positive result indicates a higher risk, and further testing may be recommended. It’s essential to discuss results with your healthcare provider for proper interpretation and guidance.
Test Name and Price
| Test Name | Discount Price | Regular Price |
|---|---|---|
| Maternal Serum Screen 2 Advanced Reflex to Maternal Blood for Fetal DNA MBFD Chromosome 21 Test | 70,000 NGN | 100,000 NGN |
Booking the Test
To schedule your Maternal Serum Screen 2 Advanced Reflex to Maternal Blood for Fetal DNA MBFD Chromosome 21 Test, please contact us at +2348077798758 or visit our website to book online. Ensure the health and well-being of your baby with this essential prenatal screening.
Pre-Test Instructions
Please provide the following information before the test:
- Maternal Date of Birth (dd/mm/yy)
- Last Menstrual Period (LMP) or Ultrasound date
- Number of Fetuses (Single/Twins)
- Diabetic status and Body Weight in Kg
- IVF status, Smoking history, and Previous history of Trisomy 21 pregnancy
All positive results will require a submission of 10 mL whole blood in a special tube available from LPL for MBFD-21/NIPT along with a duly filled consent form (Form 12). Please ensure to ship samples refrigerated and do not freeze. This test is valid between 10-13 weeks gestation.
